Ascentage Pharma Group International (AAPG) Other Non-Current Assets (2022 - 2025)
Historic Other Non-Current Assets for Ascentage Pharma Group International (AAPG) over the last 4 years, with Q2 2025 value amounting to $13.8 million.
- Ascentage Pharma Group International's Other Non-Current Assets changed N/A to $13.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $13.8 million, marking a year-over-year change of. This contributed to the annual value of $8.1 million for FY2024, which is 13401.21% up from last year.
- Ascentage Pharma Group International's Other Non-Current Assets amounted to $13.8 million in Q2 2025.
- In the past 5 years, Ascentage Pharma Group International's Other Non-Current Assets registered a high of $13.8 million during Q2 2025, and its lowest value of $2.3 million during Q4 2022.
- For the 4-year period, Ascentage Pharma Group International's Other Non-Current Assets averaged around $7.0 million, with its median value being $5.8 million (2023).
- As far as peak fluctuations go, Ascentage Pharma Group International's Other Non-Current Assets skyrocketed by 4599.97% in 2023, and later skyrocketed by 14225.94% in 2024.
- Quarter analysis of 4 years shows Ascentage Pharma Group International's Other Non-Current Assets stood at $2.3 million in 2022, then soared by 46.0% to $3.4 million in 2023, then skyrocketed by 142.26% to $8.3 million in 2024, then soared by 67.49% to $13.8 million in 2025.
- Its Other Non-Current Assets stands at $13.8 million for Q2 2025, versus $8.3 million for Q4 2024 and $3.4 million for Q4 2023.